Business Wire

Aptar Pharma's Preservative-Free Multidose Dispenser Chosen for the First Time for a Prescription Dry Eye Product in the US with RESTASIS MULTIDOSE™

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the U.S. prescription market for the ...
PharmTech

pharma& Secures MHRA Approval for Pegasys API Production at Loba Biotech

MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients. Following the MHRA decision, pharma& expects that ...
Nasdaq

Empower Clinics Signs North American Distribution Agreement with API Pharma USA For FDA EUA COVID-Rapid Antigen & Antibody Tests. Supported Three Months of Clinical Trials

EMPOWER'S KAI Medical Laboratory Also Supporting API Pharma With Health Canada Submission of COVID Rapid Antigen Test and Signs National Distribution Agreement VANCOUVER, BC / ACCESSWIRE / November 30 ...
PharmTech

CPHI Frankfurt 2025: The Current API Market

Pharmaceutical Technology® spoke with Dr. Weite Oldenziel, CEO of Ofichem, before CPHI Frankfurt 2025 to get his perspective on the API market and why it is important to qualify API suppliers. APIs ...
PharmiWeb

Active Pharmaceutical Ingredient (API) Market Size, Share and Growth Report 2025-2034

The Active Pharmaceutical Ingredient (API) Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As industries ...